For early prostate cancer, 'active surveillance' is now the number 1 choice
Three decades after UC San Francisco pioneered "active surveillance" for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.